Professor Marilyn Cruickshank is the President of the Australasian College of Infection Prevention and Control (ACIPC) and Professor of Nursing Research at University of Technology Sydney. Prior to this Professor Cruickshank was Director of the national HAI program at the Australian Commission on Safety and Quality in Healthcare for a ten year period where she led work on national HAI surveillance, the national hand hygiene program, antimicrobial stewardship, national infection control guidelines. Professor Cruickshank led the development of Standard 3 of the National Safety and Quality Health Service Standards – Preventing and controlling healthcare associated infection standard which forms the basis for the hospital and dental accreditation scheme.

Luca Guardabassi is professor at the Faculty of Health and Medical Sciences, University of Copenhagen. He is an internationally recognized One Health microbiologist specialized in antimicrobial resistance with over 160 publications in peer-reviewed journals. As part of his honorary office, he chairs the ESCMID Study Group for Veterinary Microbiology (ESGVM) and the Therapeutic Guidelines Group in WSAVA, and is member of the WSAVA One Health Committee, the European veterinary subcommittee on antimicrobial susceptibility testing (VetCAST) and various national and international working groups for antimicrobial guidelines in veterinary medicine.

Sponsored by:

Professor Brendan Murphy is the Chief Medical Officer for the Australian Government and is the principal medical adviser to the Minister and the Department of Health. He also holds direct responsibility for the Department of Health’s Office of Health Protection and the Workforce Division. Apart from the many committees he chairs, co-chairs and participates, he is the Australian Member on the International Agency for Research on Cancer (IARC) Governing Committee and represents Australia at the World Health Assembly.

Prior to his appointment Professor Murphy was the Chief Executive Officer of Austin Health in Victoria.

Professor Murphy is a Professorial Associate with the title of Professor at the University of Melbourne and an Adjunct Professor at Monash University, a Fellow of the Australian Academy of Health and Medical Sciences, a Fellow of the Royal Australian College of Physicians and Australian Institute of Company Directors.

He was formerly CMO and director of Nephrology at St Vincent’s Health, and sat on the Boards of Health Workforce Australia, the Florey Institute of Neuroscience and Mental Health, the Olivia Newton-John Cancer Research Institute and the Victorian Comprehensive Cancer Centre. He is also a former president of the Australian and New Zealand Society of Nephrology.

Stephen is a consultant veterinary clinical pharmacologist and toxicologist and founder and sole director of Advanced Veterinary Therapeutics, a consulting company that provides advice on appropriate use of veterinary medicines to veterinarians, veterinary organisations (Australian Veterinary Association, World Veterinary Association, World Organisation for Animal Health), state and national government departments and statutory bodies (APVMA, Department of Agriculture, Department of Health, US Environmental Protection Agency), and global organisations (OIE, FAO, Chatham House).

His is a member of the AVA Committee on Antimicrobial Resistance, a member of the ASTAG committee on antimicrobial prioritisation, in 2017 became President of the ANZCVS Chapter of Pharmacology, and is a member of the World Veterinary Association Pharmaceutical Stewardship Committee.

He has more than 100 publications on which he is author or editor, including chapters on antimicrobial stewardship, clinical pharmacology, adverse drug reactions, use of antimicrobial agents in livestock, and antimicrobial drug discovery and models of infection.

He has been a teacher and facilitator of courses at the University of Sydney on food safety, public health and antimicrobial resistance since 2003.

He regularly is invited to speak nationally and internationally at a broad range of conferences and symposia especially on the subjects of antimicrobial use, antimicrobial stewardship and risk assessment.  He gave his first presentation on veterinary antimicrobial resistance and stewardship at the AVA Conference in Perth in 2000 and remains passionate about improving the use and effective life span of antimicrobial agents.

Sponsored by:

John F. Prescott is a retired veterinary bacteriologist and University Professor Emeritus at the University of Guelph. He is best known for work on Rhodococcus equi pneumonia in foals, Clostridium perfringens enteritis in several species, and for promoting better use of antimicrobial drug use in animals.  He is an editor and an author of the textbook “Antimicrobial Therapy in Veterinary Medicine”, now in its fifth edition. He has been active in promoting antimicrobial stewardship in Canadian agriculture and veterinary medicine for many years. He was elected a Fellow of the Canadian Academy of Health Sciences in 2008.

Sponsored by: 

Mark Schipp was appointed Australian Chief Veterinary Officer in 2011.  In 2012 he was elected to the OIE Council and in 2015 was elected Vice President of the OIE General Assembly. He is chair of Wildlife Health Australia management committee. 

Together with the Chief Medical Officer, Dr Schipp chairs the Australian Strategic and Technical Advisory Group on Antimicrobial Resistance. Previously Dr Schipp has held positions responsible for animal derived food product inspection, market access and export certification.  

Dr Schipp served two terms overseas as Agriculture Counsellor in Seoul, South Korea and in Beijing, China.   

Mark is a biology and veterinary graduate of Murdoch University. After graduation he worked with the Western Australian Department of Agriculture.

Matthew Stone is a veterinary epidemiologist from New Zealand, and the Deputy Director General – International Standards and Science at the World Organisation for Animal Health (OIE) at their Paris headquarters.  After five years in mixed veterinary practice, Matthew worked for the next 20 years with the government veterinary authority of New Zealand, the Ministry for Primary Industries, serving in numerous veterinary and management roles, including as the New Zealand Delegate to the OIE. In that capacity he served as the Secretary General for the OIE Asia Far East and Oceania region. Matthew has been President of the Epidemiology Branch of the New Zealand Veterinary Association; and a member of the Professional Standards Committee of the New Zealand Veterinary Council; the Stakeholder Council for the New Zealand Tb Free and National Animal Identification and Traceability programmes; and the Wellington SPCA Board. In OIE Matthew oversees the organisation’s processes for setting international standards; the global strategies for FMD, PPR, Rabies and AMR; and represents OIE on the UN Inter-Agency Coordination Group for AMR